(Q39420935)

11 September 2017

Celecoxib versus diclofenac in the management of osteoarthritis of the knee (English)

1 reference

11 September 2017

0 references

1 reference

McKenna F

1

1 reference

11 September 2017

Borenstein D

2

1 reference

11 September 2017

Wendt H

3

1 reference

11 September 2017

Wallemark C

4

1 reference

11 September 2017

Lefkowith JB

5

1 reference

11 September 2017

Geis GS

6

1 reference

11 September 2017

language of work or name

1 reference

1 January 2001

1 reference

Scandinavian Journal of Rheumatology

11 September 2017

1 reference

11 September 2017

30

1 reference

11 September 2017

11-18

1 reference

11 September 2017

1

1 reference

Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis

11 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F030097401750065265

Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097401750065265

Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097401750065265

Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097401750065265

Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097401750065265

Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097401750065265

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097401750065265

Intestinal toxicity of non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F030097401750065265

21 January 2018

Towards a better aspirin

1 reference

https://api.crossref.org/works/10.1080%2F030097401750065265

10.1080/030097401750065265

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference